Interventional Radiology Market

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations

2.1. Market Coverage
2.2. Market Definition

3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Interventional Radiology Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4.1. Interventional Radiology Market, by Key Countries
4.2. Interventional Radiology Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Interventional Radiology Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Interventional Radiology Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032
8.3.1. MRI Systems
8.3.2. CT Scanners
8.3.3. Ultrasound Imaging Systems
8.3.4. Angiography Systems
8.3.5. Others
8.4. Market Attractiveness Analysis By Product

9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Ambulatory Surgical Centres
9.3.4. Others
9.4. Market Attractiveness Analysis By End-use

10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Procedure, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Procedure, 2022-2032
10.3.1. Angioplasty
10.3.2. Biopsy
10.3.3. Embolization
10.3.3.1. Peripheral Embolization
10.3.3.2. Prostatic Artery Embolization
10.3.3.3. Genicular Artery Embolization
10.3.3.4. Fibroid
10.3.3.5. Others
10.3.4. Thrombolysis
10.3.5. Vertebroplasty
10.3.6. Nephrostomy
10.3.7. Interventional Oncology
10.3.8. MSK Intervention
10.3.9. Others
10.4. Market Attractiveness Analysis By Procedure

11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
11.3.1. Cardiology
11.3.2. Oncology
11.3.3. Urology
11.3.4. Gastroenterology
11.3.5. Obstetrics
11.3.6. Gynaecology
11.3.7. Others
11.4. Market Attractiveness Analysis By Application

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Product
13.4.3. By End-use
13.4.4. By Application
13.4.5. By Procedure
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By End-use
13.5.4. By Application
13.5.5. By Procedure

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product
14.4.3. By End-use
14.4.4. By Application
14.4.5. By Procedure
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By End-use
14.5.4. By Application
14.5.5. By Procedure

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Product
15.4.3. By End-use
15.4.4. By Application
15.4.5. By Procedure
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End-use
15.5.4. By Application
15.5.5. By Procedure

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Product
16.4.3. By End-use
16.4.4. By Application
16.4.5. By Procedure
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By End-use
16.5.4. By Application
16.5.5. By Procedure

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product
17.4.3. By End-use
17.4.4. By Application
17.4.5. By Procedure
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By End-use
17.5.4. By Application
17.5.5. By Procedure

18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Interventional Radiology Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.2.2.1. By Product
18.2.2.2. By End-use
18.2.2.3. By Application
18.2.2.4. By Procedure
18.3. Canada Interventional Radiology Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.3.2.1. By Product
18.3.2.2. By End-use
18.3.2.3. By Application
18.3.2.4. By Procedure
18.4. Mexico Interventional Radiology Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.4.2.1. By Product
18.4.2.2. By End-use
18.4.2.3. By Application
18.4.2.4. By Procedure
18.5. Brazil Interventional Radiology Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.5.2.1. By Product
18.5.2.2. By End-use
18.5.2.3. By Application
18.5.2.4. By Procedure
18.6. Germany Interventional Radiology Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.6.2.1. By Product
18.6.2.2. By End-use
18.6.2.3. By Application
18.6.2.4. By Procedure
18.7. France Interventional Radiology Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.7.2.1. By Product
18.7.2.2. By End-use
18.7.2.3. By Application
18.7.2.4. By Procedure
18.8. Italy Interventional Radiology Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.8.2.1. By Product
18.8.2.2. By End-use
18.8.2.3. By Application
18.8.2.4. By Procedure
18.9. BENELUX Interventional Radiology Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.9.2.1. By Product
18.9.2.2. By End-use
18.9.2.3. By Application
18.9.2.4. By Procedure
18.10. UK Interventional Radiology Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.10.2.1. By Product
18.10.2.2. By End-use
18.10.2.3. By Application
18.10.2.4. By Procedure
18.11. Nordic Countries Interventional Radiology Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.11.2.1. By Product
18.11.2.2. By End-use
18.11.2.3. By Application
18.11.2.4. By Procedure
18.12. China Interventional Radiology Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.12.2.1. By Product
18.12.2.2. By End-use
18.12.2.3. By Application
18.12.2.4. By Procedure
18.13. Japan Interventional Radiology Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.13.2.1. By Product
18.13.2.2. By End-use
18.13.2.3. By Application
18.13.2.4. By Procedure
18.14. South Korea Interventional Radiology Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.14.2.1. By Product
18.14.2.2. By End-use
18.14.2.3. By Application
18.14.2.4. By Procedure
18.15. GCC Countries Interventional Radiology Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.15.2.1. By Product
18.15.2.2. By End-use
18.15.2.3. By Application
18.15.2.4. By Procedure
18.16. South Africa Interventional Radiology Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.16.2.1. By Product
18.16.2.2. By End-use
18.16.2.3. By Application
18.16.2.4. By Procedure
18.17. Turkey Interventional Radiology Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.17.2.1. By Product
18.17.2.2. By End-use
18.17.2.3. By Application
18.17.2.4. By Procedure
18.17.3. Competition Landscape and Player Concentration in the Country

19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Koninklijke Philips N. V
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Carestream Health Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Hologic, Inc.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. GE Healthcare
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Fujifilm Corporation
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Samsung Healthcare (Samsung Electronics Co., Ltd.)
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Shimadzu Corporation
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Siemens Healthineers
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Canon Medical Systems Corporation
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Olympus Corporation
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview